{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:12:37Z","timestamp":1772737957831,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pharma.2025.07.009","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:43:42Z","timestamp":1753253022000},"page":"35-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesizing safety data on novel intravaginal formulations: A comprehensive scoping review of in vivo and in vitro research"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-0481","authenticated-orcid":false,"given":"Athul","family":"TP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjani","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanshika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-5801","authenticated-orcid":false,"given":"R.","family":"Galib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Jachak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-442X","authenticated-orcid":false,"given":"Tanuja","family":"Nesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena S.","family":"Deogade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0535","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/ayu.AYU_54_15","article-title":"Dhatakyadi Varti\u00a0\u2013\u00a0an effective local treatment for Upapluta Yonivyapad (vulvovaginitis during pregnancy): a standard controlled randomized clinical trial","volume":"37","author":"Shaikh","year":"2016","journal-title":"AYU"},{"key":"10.1016\/j.pharma.2025.07.009_bib0540","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/tog.12515","article-title":"Gynaecological disease in the developing world: a silent pandemic","volume":"20","author":"Wijeratne","year":"2018","journal-title":"Obstet Gynaecol"},{"key":"10.1016\/j.pharma.2025.07.009_bib0545","first-page":"1","article-title":"Recent advances in medically assisted conception. Report of a WHO Scientific Group","volume":"820","year":"1992","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.pharma.2025.07.009_bib0550","doi-asserted-by":"crossref","first-page":"113865","DOI":"10.1016\/j.addr.2021.113865","article-title":"Women-specific routes of administration for drugs: a critical overview","volume":"176","author":"das Neves","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0555","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2007.08.010","article-title":"Intravaginal oestrogen and progestin administration: advantages and disadvantages","volume":"22","author":"Cicinelli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0560","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtcme.2016.02.002","article-title":"A glimpse of Ayurveda\u00a0\u2013\u00a0the forgotten history and principles of Indian traditional medicine","volume":"7","author":"Jaiswal","year":"2017","journal-title":"J Tradit Complement Med"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0565","doi-asserted-by":"crossref","first-page":"144","DOI":"10.17795\/jjnpp-9990","article-title":"Nasal drug delivery in traditional Persian medicine","volume":"8","author":"Zarshenas","year":"2013","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"10.1016\/j.pharma.2025.07.009_bib0570","first-page":"223","article-title":"A brief review on vaginal drug delivery in traditional Persian medicine","volume":"3","author":"Askari","year":"2018","journal-title":"Tradit Integr Med"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0575","article-title":"Vaginal and rectal dosage forms in Iranian traditional pharmacy","volume":"10","author":"Jahromi","year":"2015","journal-title":"Jundishapur J Nat Pharm Prod"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0580","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/jcim-2020-0048","article-title":"\u2018Il\u0101j bi\u2019l-Tadb\u012br (regimenal therapy): a core mode of Unani treatment","volume":"18","author":"Ansari","year":"2021","journal-title":"J Complement Integr Med"},{"key":"10.1016\/j.pharma.2025.07.009_bib0585","series-title":"Research C for DE and. Study and evaluation of sex differences in the clinical evaluation of drugs","year":"2025"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0590","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12248-021-00602-z","article-title":"Perspectives on existing and novel alternative intravaginal probiotic delivery methods in the context of bacterial vaginosis infection","volume":"23","author":"Chandrashekhar","year":"2021","journal-title":"AAPS J"},{"issue":"12","key":"10.1016\/j.pharma.2025.07.009_bib0595","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/biomedicines10123036","article-title":"Novel mucoadhesive wafers for treating local vaginal infections","volume":"10","author":"Alzainy","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0600","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45439-7","article-title":"Intravaginal administration of progesterone: enhanced absorption after estrogen treatment","volume":"35","author":"Villanueva","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharma.2025.07.009_bib0605","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2017.12.004","article-title":"Polymeric gels for intravaginal drug delivery","volume":"270","author":"Cook","year":"2018","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.pharma.2025.07.009_bib0610","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1128\/AAC.01198-12","article-title":"Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0615","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00192-012-2009-3","article-title":"The vagina as a route for drug delivery: a review","volume":"24","author":"Srikrishna","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0620","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.009_bib0625","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.50.5.1696-1700.2006","article-title":"Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model","volume":"50","author":"Patton","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0630","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/01926230490274362","article-title":"Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein","volume":"32","author":"D\u2019Cruz","year":"2004","journal-title":"Toxicol Pathol"},{"issue":"9","key":"10.1016\/j.pharma.2025.07.009_bib0635","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1080\/10717544.2016.1205158","article-title":"Vaginal delivery of carboplatin-loaded thermosensitive hydrogel to prevent local cervical cancer recurrence in mice","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv"},{"issue":"9","key":"10.1016\/j.pharma.2025.07.009_bib0640","doi-asserted-by":"crossref","first-page":"e108109","DOI":"10.1371\/journal.pone.0108109","article-title":"A MIV-150\/Zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants","volume":"9","author":"Barnable","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharma.2025.07.009_bib0645","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/10611860500441933","article-title":"Rectal vaginal administration of insulin\u2013chitosan formulations: an experimental study in rabbits","volume":"13","author":"De\u011fim","year":"2005","journal-title":"J Drug Target"},{"key":"10.1016\/j.pharma.2025.07.009_bib0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102897","article-title":"An effective vaginal gel to deliver CRISPR\/Cas9 system encapsulated in poly (\u03b2-amino ester) nanoparticles for vaginal gene therapy","volume":"58","author":"Niu","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0655","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10717544.2019.1568622","article-title":"A thermosensitive gel based on w1\/o\/w2 multiple microemulsions for the vaginal delivery of small nucleic acid","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0660","first-page":"458","article-title":"In vivo evaluation of an in-situ hydrogel system for vaginal administration","volume":"69","author":"Li","year":"2014","journal-title":"Pharm Int J Pharm Sci"},{"key":"10.1016\/j.pharma.2025.07.009_bib0665","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejps.2017.10.002","article-title":"Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis","volume":"111","author":"Kenechukwu","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0670","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(02)00086-X","article-title":"Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis","volume":"82","author":"Yun Chang","year":"2002","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.pharma.2025.07.009_bib0675","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/gels9100787","article-title":"Intravaginal gel for sustained delivery of occidiofungin and long-lasting antifungal effects","volume":"9","author":"Cothrell","year":"2023","journal-title":"Gels"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0680","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.762","article-title":"Lack of adverse effects on fertility of female cd-1 mice exposed to repetitive intravaginal gel\u2013microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07)","volume":"21","author":"D\u2019Cruz","year":"2001","journal-title":"J Appl Toxicol"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0685","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/taap.2000.9089","article-title":"Intravaginal toxicity studies of a gel-microemulsion formulation of spermicidal vanadocenes in rabbits","volume":"170","author":"D\u2019Cruz","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0690","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0010-7824(99)00118-3","article-title":"Evaluation of subchronic (13 weeks) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-05) in B6C3F1 mice","volume":"61","author":"D\u2019Cruz","year":"2000","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0695","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1208\/pt020205","article-title":"GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion","volume":"2","author":"D\u2019Cruz","year":"2001","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.pharma.2025.07.009_bib0700","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1128\/AAC.00082-16","article-title":"Safety and pharmacokinetics of quick-dissolving polymeric vaginal films delivering the antiretroviral IQP-0528 for preexposure prophylaxis","volume":"60","author":"Srinivasan","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0705","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03639045.2017.1399272","article-title":"Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV","volume":"44","author":"Khan","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"9","key":"10.1016\/j.pharma.2025.07.009_bib0710","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1128\/AAC.02871-14","article-title":"Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model","volume":"58","author":"Moss","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0715","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.pharma.2025.07.009_bib0720","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jphp.12240","article-title":"Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis","volume":"66","author":"De Bernardis","year":"2014","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"10.1016\/j.pharma.2025.07.009_bib0725","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.xphs.2017.03.030","article-title":"Evaluation of vaginal drug levels and safety of a locally administered glycerol monolaurate cream in rhesus macaques","volume":"106","author":"Kirtane","year":"2017","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0730","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/10717544.2017.1375575","article-title":"Expansible thermal gelling foam aerosol for vaginal drug delivery","volume":"24","author":"Mei","year":"2017","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0735","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.xphs.2020.02.016","article-title":"Vaginal suppositories containing SHetA2 to treat cervical dysplasia: pharmacokinetics of daily doses and preliminary safety profile","volume":"109","author":"Mahjabeen","year":"2020","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0740","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2008.04.005","article-title":"Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits","volume":"43","author":"Aranha","year":"2008","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0745","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2015.02.017","article-title":"A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation","volume":"285","author":"Fichorova","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0750","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.qco.0000200291.37909.3b","article-title":"Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides","volume":"19","author":"Madan","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0755","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/026119291103900403","article-title":"Vaginal irritation models: the current status of available alternative and in vitro tests","volume":"39","author":"Costin","year":"2011","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.pharma.2025.07.009_bib0760","doi-asserted-by":"crossref","first-page":"110387","DOI":"10.1016\/j.contraception.2024.110387","article-title":"A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep","volume":"133","author":"Davis","year":"2024","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0825","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/13547500701600670","article-title":"Biomarkers of leukocyte traffic and activation in the vaginal mucosa","volume":"12","author":"Trifonova","year":"2007","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0830","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jat.1262","article-title":"Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models","volume":"28","author":"Piret","year":"2008","journal-title":"J Appl Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2025.07.009_bib0835","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021","article-title":"Microemulsion-based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation","volume":"365","author":"Bachhav","year":"2009","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0845","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejpb.2005.01.012","article-title":"The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test","volume":"60","author":"Dhondt","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.009_bib0850","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0015-0282(02)04210-3","article-title":"Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis","volume":"78","author":"Zaneveld","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0855","first-page":"078248","article-title":"Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal lactobacillus rhamnosus","volume":"2007","author":"Dover","year":"2007","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0860","first-page":"11","article-title":"Conceival, a novel noncontraceptive vaginal vehicle for lipophilic microbicides","volume":"6","author":"D\u2019Cruz","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.pharma.2025.07.009_bib0865","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00002030-199810000-00004","article-title":"Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent","volume":"12","author":"Balzarini","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.pharma.2025.07.009_bib0880","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.2147\/IJN.S211691","article-title":"Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections","volume":"14","author":"Vani\u0107 \u017d","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0885","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0278-6915(82)80247-0","article-title":"pH and the potential irritancy of douche formulations to the vaginal mucosa of the albino rabbit and rat","volume":"20","author":"Kaminsky","year":"1982","journal-title":"Food Chem Toxicol"},{"issue":"29","key":"10.1016\/j.pharma.2025.07.009_bib0890","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2174\/138161205774580697","article-title":"Preclinical studies of alkylureas as Anti-HIV-1 contraceptive","volume":"11","author":"Rubinstein","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.pharma.2025.07.009_bib0900","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/10611860500441933","article-title":"Rectal and vaginal administration of insulin\u2013chitosan formulations: an experimental study in rabbits","volume":"13","author":"De\u011fim","year":"2005","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0765","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0300-483X(02)00319-0","article-title":"Two-year toxicity and carcinogenicity studies in B6C3F1 mice with 5-bromo-6-methoxy-5,6-dihydro-3\u2032-azidothymidine-5\u2032-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent","volume":"179","author":"D\u2019Cruz","year":"2002","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0770","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.maturitas.2012.05.007","article-title":"Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations","volume":"72","author":"L\u00f3pez-Belmonte","year":"2012","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0775","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1208\/s12248-016-0007-y","article-title":"Spray-dried thiolated chitosan-coated sodium alginate multilayer microparticles for vaginal HIV microbicide delivery","volume":"19","author":"Meng","year":"2017","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0780","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0010-7824(02)00354-2","article-title":"Characterization of a female-controlled drug delivery system for microbicides","volume":"66","author":"Wang","year":"2002","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0785","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/dkg001","article-title":"Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07)","volume":"50","author":"D\u2019Cruz","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0790","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jat.1280","article-title":"Evaluation of local tolerance of the antiretroviral spermicide (WHI-07)-loaded gel-microemulsion in the porcine female reproductive tract","volume":"28","author":"D\u2019Cruz","year":"2008","journal-title":"J Appl Toxicol"},{"issue":"11","key":"10.1016\/j.pharma.2025.07.009_bib0795","doi-asserted-by":"crossref","first-page":"e15111","DOI":"10.1371\/journal.pone.0015111","article-title":"The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques","volume":"5","author":"Cole","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2025.07.009_bib0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.theriogenology.2020.11.013","article-title":"Effect of intramuscular and intravaginal PGE-2 treatment compared to intramuscular oxytocin treatment in eutocic sows on the farrowing performance in a free farrowing system","volume":"161","author":"Bill","year":"2021","journal-title":"Theriogenology"},{"issue":"7","key":"10.1016\/j.pharma.2025.07.009_bib0805","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1080\/01926230701748115","article-title":"Preclinical evaluation of a dual-acting microbicidal prodrug WHI-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat","volume":"35","author":"D\u2019Cruz","year":"2007","journal-title":"Toxicol Pathol"},{"issue":"7","key":"10.1016\/j.pharma.2025.07.009_bib0810","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/AAC.04954-14","article-title":"The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides","volume":"59","author":"Holt","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharma.2025.07.009_bib0815","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jri.2017.09.014","article-title":"Evaluation of immunological markers of ovine vaginal irritation: Implications for preclinical assessment of non-vaccine HIV preventive agents","volume":"124","author":"Milligan","year":"2017","journal-title":"J Reprod Immunol"},{"issue":"15","key":"10.1016\/j.pharma.2025.07.009_bib0820","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/01.aids.0000185990.16477.47","article-title":"Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques","volume":"19","author":"Ratterree","year":"2005","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0910","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/pharmaceutics14061295","article-title":"Toxicity assessment of resveratrol liposomes-in-hydrogel delivery system by EpiVaginal\u2122 tissue model","volume":"14","author":"J\u00f8raholmen","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0915","doi-asserted-by":"crossref","first-page":"035017","DOI":"10.1088\/1748-605X\/ab04e1","article-title":"Biocompatible polyvinyl alcohol and RISUG\u00ae blend polymeric films with spermicidal potential","volume":"14","author":"Subramanian","year":"2019","journal-title":"Biomed Mater"},{"key":"10.1016\/j.pharma.2025.07.009_bib0920","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.07.018","article-title":"Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: development and characterization","volume":"96","author":"Bassi","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.pharma.2025.07.009_bib0840","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1095\/biolreprod.104.029603","article-title":"Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives1","volume":"71","author":"Fichorova","year":"2004","journal-title":"Biol Reprod"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib0875","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.fertnstert.2007.01.131","article-title":"Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1","volume":"88","author":"D\u2019Cruz","year":"2007","journal-title":"Fertil Steril"},{"issue":"Suppl. 3","key":"10.1016\/j.pharma.2025.07.009_bib0905","first-page":"S174","article-title":"Preclinical assessment of the proinflammatory potential of microbicide candidates","volume":"37","author":"Doncel","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.pharma.2025.07.009_bib0925","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jps.22781","article-title":"A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781","volume":"101","author":"Clark","year":"2012","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0930","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tox.2010.10.001","article-title":"Development of an in vitro alternative assay method for vaginal irritation","volume":"279","author":"Ayehunie","year":"2011","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.pharma.2025.07.009_bib0935","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/jps.22529","article-title":"Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention","volume":"100","author":"Alukda","year":"2011","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.009_bib0940","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/AAC.01190-10","article-title":"Formulation development of retrocyclin 1 analog RC-101 as an Anti-HIV vaginal microbicide product","volume":"55","author":"Sassi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharma.2025.07.009_bib0945","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.actbio.2021.02.029","article-title":"Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis","volume":"125","author":"Facchinatto","year":"2021","journal-title":"Acta Biomater"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.009_bib0950","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol Med"},{"issue":"23","key":"10.1016\/j.pharma.2025.07.009_bib0955","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.3390\/ijms222312827","article-title":"Assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0960","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.pharma.2025.07.009_bib0965","first-page":"37","article-title":"Cell viability assays. Assay guidance manual [Internet]. 2016.88. Buschmann J. The OECD guidelines for the testing of chemicals and pesticides","volume":"947","author":"Riss","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharma.2025.07.009_bib0970","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-62703-131-8_4","article-title":"The OECD guidelines for the testing of chemicals and pesticides","volume":"947","author":"Buschmann","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0975","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623315570339","article-title":"Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears","volume":"43","author":"Cora","year":"2015","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.pharma.2025.07.009_bib0980","series-title":"Genital system","article-title":"Structure, cyclic change, and function, vagina and vulva, rat","author":"Yuan","year":"1987"},{"key":"10.1016\/j.pharma.2025.07.009_bib0895","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vascn.2018.04.001","article-title":"The rabbit vagina as an in vivo model for vaginal fenticonazole permeability and toxicity","volume":"94","author":"Campos","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"Pt 2","key":"10.1016\/j.pharma.2025.07.009_bib0985","first-page":"239","article-title":"Some observations on the development of the vagina in the pig","volume":"68","author":"Baxter","year":"1934","journal-title":"J Anat"},{"key":"10.1016\/j.pharma.2025.07.009_bib0990","doi-asserted-by":"crossref","first-page":"104680","DOI":"10.1016\/j.tiv.2019.104680","article-title":"Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT)","volume":"62","author":"Costin","year":"2020","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"10.1016\/j.pharma.2025.07.009_bib0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib0870","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1095\/biolreprod.103.019182","article-title":"Development and evaluation of a thermo reversible ovule formulation of stampidine, a novel non spermicidal broad-spectrum anti-human immunodeficiency virus microbicide1","volume":"69","author":"D\u2019Cruz","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.pharma.2025.07.009_bib1000","series-title":"Encyclopedia of pharmaceutical science and technology, six volume set (print)","article-title":"Drug delivery: vaginal route","author":"Lee","year":"2013"},{"issue":"22","key":"10.1016\/j.pharma.2025.07.009_bib1005","doi-asserted-by":"crossref","first-page":"14344","DOI":"10.3390\/ijms232214344","article-title":"Reliability of rodent and rabbit models in preeclampsia research","volume":"23","author":"Sakowicz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharma.2025.07.009_bib1010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.109.065706","article-title":"Of mice and humans: are they the same?\u00a0\u2013\u00a0Implications in cancer translational research","volume":"51","author":"de Jong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharma.2025.07.009_bib1015","first-page":"100112","article-title":"In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel","volume":"4","author":"Murphy","year":"2022","journal-title":"Int J Pharm X"},{"issue":"10","key":"10.1016\/j.pharma.2025.07.009_bib1020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/pharmaceutics11100538","article-title":"In vitro methods for evaluating drug release of vaginal ring formulations\u00a0\u2013\u00a0a critical review","volume":"11","author":"Tietz","year":"2019","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.pharma.2025.07.009_bib1025","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3390\/diagnostics11111996","article-title":"Vaginal pH value for clinical diagnosis and treatment of common vaginitis","volume":"11","author":"Lin","year":"2021","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.pharma.2025.07.009_bib1030","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/pharmaceutics13060884","article-title":"Recent advances in polymer-based vaginal drug delivery systems","volume":"13","author":"Osma\u0142ek","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.pharma.2025.07.009_bib1035","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.02446-14","article-title":"Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis","volume":"58","author":"Sundara Rajan","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.pharma.2025.07.009_bib1040","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/biomedicines10123036","article-title":"Novel mucoadhesive wafers for treating local vaginal infections","volume":"10","author":"Alzainy","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.pharma.2025.07.009_bib1045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jps.2600710712","article-title":"Medicated tampons: intravaginal sustained administration of metronidazole and in vitro-in vivo relationships","volume":"71","author":"Chien","year":"1982","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2025.07.009_bib1050","doi-asserted-by":"crossref","first-page":"1224421","DOI":"10.3389\/frph.2023.1224421","article-title":"Menstrual tampons and vaginal pessaries: regulation of intravaginal medical devices by the US FDA","volume":"5","author":"Pollard","year":"2023","journal-title":"Front Reprod Health"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:56:40Z","timestamp":1766192200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003450925001154"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.07.009","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesizing safety data on novel intravaginal formulations: A comprehensive scoping review of in vivo and in vitro research","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}